Neurodegeneration & Inflammation

Project Overview

Active Biotech focuses on the research and development of pharmaceuticals in therapeutic areas with high medical need and in which the body’s immune system is of central importance. The project portfolio comprises small, orally active immunomodulatory molecules as well as antibody-based immunotherapy. The projects are in development for cancer as well as neurodegenerative and inflammatory diseases.

Therapeutic areas of high medical need


Disease Area
Phase 1
Phase 2
Phase 3
ANYARA Combination with anti-PD1 in solid tumors*
Tasquinimod Multiple Myeloma
SILC Cancer indications
Neurodegeneration & Inflammation
Laquinimod Huntington's Disease (Legato-HD)**
Paquinimod Systemic Sclerosis
* Study preparations ongoing
** Complete analysis of study ongoing